Melanoma CPG Mini-Module – Multidisciplinary care for resectable melanoma

The SITC Cancer Immunotherapy Guidelines Webinars connect clinicians with leading experts in the field and provide education about the evidence- and consensus-based recommendations in the clinical practice guidelines. To complement the advanced live webinar series, three on-demand, mini modules will assist learners in applying lessons learned on specific topics within the use of immunotherapy in their own practices and locate additional resources to continue their education.

Tina Hieken, MD, of Mayo Clinic, presents a case study of a patient with resectable melanoma and addresses benefits associated with immune checkpoint blockade therapy in the neoadjuvant and adjuvant settings. Discussion between Dr. Hieken with panelists Elizabeth Buchbinder, MD, of Dana-Farber Cancer Institute and April Salama, MD, of the Duke Cancer Institute touches on considerations for selecting appropriate treatment for patients, unanswered questions regarding neoadjuvant treatment, the need for larger clinical trials addressing immunotherapy in the neoadjuvant setting, and the importance of multidisciplinary care when treating patients with resectable disease.

Run time: Approximately 11 minutes

Target Audience
Clinicians and advanced practice providers who treat cancer patients are the target audience, including community physicians, oncologists, emergency room physicians, disease specialists, registered nurses, nurse practitioners, pharmacists, physician assistants, and radiologists. 

SITC Online Education Disclaimer
A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described
in this educational activity. 

The Mini Modules are part of the Cancer Immunotherapy Clinical Practice Guidelines Advanced Webinar Series supported, in part, by grants from Amgen and Merck & Co., Inc. (as of 09/07/2023). 

The SITC Clinical Practice Guidelines are produced and funded solely by SITC. No outside funding is received for the development of the manuscripts.